Global DNA nanotechnology market is anticipated to grow with an impressive CAGR in the forecast years 2023-2027 on account of increasing advancement in nanotechnology and its application in healthcare sector. Surge in demand for the effective and efficient drug delivery system is inclining pharmaceutical companies to invest in the research and development of nano particles, and thus driving the future growth of the global DNA nanotechnology market in the upcoming five years.

Nanotechnology is the process of using atomic level of any material such that industrial purposes can be resolved effectively. The technology finds its application in multiple fields of science like organic chemistry, molecular biology, semiconductor physics, energy storage, microfabrication, molecular engineering, etc. Healthcare sector specifically promotes the use of nanotechnology for the production of nanomedicine, nanoelectronics, biomaterials, etc.

DNA Nanotech Applications in Pharma Drives Market Growth

Increasing adoption of nanoparticles in pharmaceuticals to provide efficient drug delivery system along with other applications is driving the growth of the global DNA nanotechnology market in the upcoming five years. DNA nanotechnology also has potential application in nanomedicine. The technology has the ability to perform computation in a biocompatible format to synthesize smart drugs such that requirement for targeted drug delivery can be achieved. According to the report on global smart drugs market, the market growth valued at USD3.87 billion in 2020.

One of the examples of such advancement include use of a hollow DNA assembly that has protein that cause apoptosis or cell death. These are actively utilized for cell termination in case of cancer patients. The DNA nanotechnology induced with apoptosis causing proteins is targeted to the tumor location in the body and these proteins when reach the target causes apoptosis to the cancerous cells thus eliminating them from the body.

Increasing Medical Expenses Support Market Growth

Increased investment from the government and private sector further drives the growth of the global DNA nanotechnology market in the upcoming five years. Healthcare industry is ever expanding, and consistent flow of investment readily supports the growth of the industry on various aspects of the market. Medical investments in the pharmaceutical sector in the United States in 2020, increased to USD539 billion.

The investment is further increasing, and with recent advanced diseases and spread of infectious diseases like COVID-19 has further drawn more investment in the healthcare sector. Requirement of the well-researched and effective therapeutics, pharmaceutical products, and medical devices, substantiate the growth of the global DNA nanotechnology market in the future five years.


Click here to download the sample

Market Segmentation

The global DNA nanotechnology market segmentation is based on type, application, end user, regional distribution, and competitive landscape. Based on type, the market is further segmented into Structural DNA Nanotechnology and Dynamic DNA Nanotechnology. Structural DNA nanotechnology consists of extended lattices, discrete structures, and templated assembly.

On the basis of application, the market is fragmentation into targeted drug delivery, smart pills, nanolithography, and others. Based on end user, the market is again bifurcated into biotechnology & pharmaceutical companies, academic & research institutions, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

NuProbe USA Inc., tilibit nanosystems GmbH, GATTAquant GmbH, Genisphere LLC, Inovio Pharmaceuticals, Inc., Novartis International AG, are enlisted in a partial list of major market players of the global DNA nanotechnology market.

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Type
  • Application
  • End User

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Egypt, Brazil, Argentina, Colombia,

Key Companies Profiled

NuProbe USA Inc., tilibit nanosystems GmbH, GATTAquant GmbH, Genisphere LLC, Inovio Pharmaceuticals, Inc., Novartis International AG.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global DNA nanotechnology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • DNA Nanotechnology Market, By Type:
    • Structural DNA Nanotechnology
      • Extended Lattices
      • Discrete Structures
      • Templated Assembly
    • Dynamic DNA Nanotechnology
      • Nanomechanical Devices
      • Strand Displacement Cascades
  • DNA Nanotechnology Market, By Application:
    • Targeted Drug Delivery
    • Smart Pills
    • Nanolithography
    • Others
  • DNA Nanotechnology Market, By End User:
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutions
    • Others
  • DNA Nanotechnology Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Egypt
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global DNA nanotechnology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global DNA Nanotechnology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global DNA Nanotechnology Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Factors Contributing to Switch Over to DNA Nanotechnology

5.2.  Barriers to Adoption of DNA Nanotechnology

5.3.  Brand Awareness

6.    Global DNA Nanotechnology Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

6.2.1.1.         Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

6.2.1.2.         Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

6.2.2.     By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

6.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

6 .2.4.     By Company (2021)

6.2.5.     By Region

6.3.  Product Market Map

7.    North America DNA Nanotechnology Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

7.2.1.1.         Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

7.2.1.2.         Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

7.2.2.     By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

7.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States DNA Nanotechnology Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Application

7.3.1.2.3.             By End User

7.3.2.     Mexico DNA Nanotechnology Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Application

7.3.2.2.3.             By End User

7.3.3.     Canada DNA Nanotechnology Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Application

7.3.3.2.3.             By End User

8.    Europe DNA Nanotechnology Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

8.2.1.1.         Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

8.2.1.2.         Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

8.2.2.     By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

8.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France DNA Nanotechnology Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Application

8.3.1.2.3.             By End User

8.3.2.     Germany DNA Nanotechnology Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Application

8.3.2.2.3.             By End User

8.3.3.     United Kingdom DNA Nanotechnology Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Application

8.3.3.2.3.             By End User

8.3.4.     Italy DNA Nanotechnology Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Application

8.3.4.2.3.             By End User

8.3.5.     Spain DNA Nanotechnology Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Application

8.3.5.2.3.             By End User

9.    Asia-Pacific DNA Nanotechnology Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

9.2.1.1.         Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

9.2.1.2.         Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

9.2.2.     By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

9.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China DNA Nanotechnology Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Application

9.3.1.2.3.             By End User

9.3.2.     India DNA Nanotechnology Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Application

9.3.2.2.3.             By End User

9.3.3.     South Korea DNA Nanotechnology Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Application

9.3.3.2.3.             By End User

9.3.4.     Japan DNA Nanotechnology Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Application

9.3.4.2.3.             By End User

9.3.5.     Australia DNA Nanotechnology Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Application

9.3.5.2.3.             By End User

10.  South America DNA Nanotechnology Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

10.2.1.1.      Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

10.2.1.2.      Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

10.2.2.  By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

10.2.3.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil DNA Nanotechnology Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Application

10.3.1.2.3.           By End User

10.3.2.  Argentina DNA Nanotechnology Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Application

10.3.2.2.3.           By End User

10.3.3.  Colombia DNA Nanotechnology Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Application

10.3.3.2.3.           By End User

11.  Middle East and Africa DNA Nanotechnology Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type (Structural DNA Nanotechnology v/s Dynamic DNA Nanotechnology)

11.2.1.1.      Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Templated Assembly)

11.2.1.2.      Dynamic DNA Nanotechnology (Nanomechanical Devices v/s Strand Displacement Cascades)

11.2.2.  By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others)

11.2.3.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa DNA Nanotechnology Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Application

11.3.1.2.3.           By End User

11.3.2.  Saudi Arabia DNA Nanotechnology Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Application

11.3.2.2.3.           By End User

11.3.3.  UAE DNA Nanotechnology Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Application

11.3.3.2.3.           By End User

11.3.4.  Egypt DNA Nanotechnology Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Application

11.3.4.2.3.           By End User

12.  Market Dynamics

12.1. Drivers

12.2. Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1. NuProbe USA Inc.

14.2. tilibit nanosystems GmbH

14.3. GATTAquant GmbH

14.4. Genisphere LLC

14.5. Inovio Pharmaceuticals, Inc.

14.6. Novartis International AG

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com